Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis

被引：1
|
作者：
Di Raimondo, Cosimo [1 ]
Rao, Ludovico [1 ]
Lozzi, Flavia [1 ]
Lombardo, Paolo [1 ]
Silvaggio, Dionisio [1 ]
Vellucci, Laura [1 ]
Tofani, Lorenzo [1 ]
Campione, Elena [1 ]
Bianchi, Luca [1 ]
机构：
[1] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 05期
关键词：
D O I：
10.1111/dth.15421
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma
    Boutros, Andrea
    Croce, Elena
    Tanda, Enrica Teresa
    Cecchi, Federica
    Arecco, Luca
    Genova, Carlo
    Baldelli, Ilaria
    Lambertini, Matteo
    Raposio, Edoardo
    Del Mastro, Lucia
    Spagnolo, Francesco
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (02)
  • [22] Cutaneous squamous cell carcinoma presenting with facial paralysis: good response to Cemiplimab
    Estenaga, Angela
    Castanon, Eduardo
    Garcia-Martinez, Francisco Javier
    Redondo, Pedro
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (03): : 448 - 450
  • [23] Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
    Gross, N. D.
    Miller, D. M.
    Khushalani, N., I
    Divi, V
    Ruiz, E. S.
    Meier, F.
    Su, Y. B.
    Swiecicki, P. L.
    Atlas, J.
    Geiger, J. L.
    Hauschild, A.
    Choe, J. H.
    Hughes, B. G. M.
    Schadendorf, D.
    Patel, V. A.
    Homsi, J.
    Taube, J. M.
    Lim, A. M.
    Ferrarotto, R.
    Kaufman, H. L.
    Seebach, F.
    Lowy, I
    Yoo, S-Y
    Mathias, M.
    Fenech, K.
    Han, H.
    Fury, M. G.
    Rischin, D.
    Lipson, E. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (17): : 1557 - 1568
  • [24] miRNA lncRNA network associated with response to cemiplimab in cutaneous squamous cell carcinoma
    Porcelli, Letizia
    De Summa, Simona
    Fasano, Rossella
    Guida, Michele
    Marvulli, Tommaso M.
    Rafaschieri, Tania
    De Palma, Giuseppe
    Serrati, Simona
    Di Fonte, Roberta
    De Risi, Ivana
    Strippoli, Sabino
    Tommasi, Stefania
    Azzariti, Amalia
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
    Proietti, Ilaria
    Tolino, Ersilia
    Bernardini, Nicoletta
    Di Fraia, Marco
    Skroza, Nevena
    Potenza, Concetta
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
  • [26] Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinoma
    Valentin, Julie
    Gerard, Emilie
    Ferte, Thomas
    Prey, Sorilla
    Dousset, Lea
    Dutriaux, Caroline
    Beylot-Barry, Marie
    Pham-Ledard, Anne
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (07) : 1110 - 1113
  • [27] Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma
    Hiller, Andrea
    Oxford, Madison
    Kulkarni, Pallavi
    Fornadley, Jeffrey
    Lo, Alexis
    Sivik, Jeffrey
    Drabick, Joseph
    Vakharia, Kavita
    ANNALS OF PLASTIC SURGERY, 2024, 92 (4S) : S129 - S131
  • [28] Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
    Strum, Scott
    Climans, Seth
    Purcell, Victoria
    Black, Morgan
    Winquist, Eric
    Ernst, Scott
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [29] Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil
    Lee, Gun Ho
    Guzman, Anthony K.
    Divito, Sherrie J.
    Soiffer, Robert J.
    Silk, Ann W.
    Schmults, Chrysalyne D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (02): : 188 - 190
  • [30] Cemiplimab as first intervention for patients with locally advanced cutaneous squamous cell carcinoma.
    Atlas, Jennifer Lynn
    Kanos, Marina
    Symanowski, James Thomas
    Brickman, Daniel
    Forster, Meghan
    Frenkel, Catherine
    Milas, Zvonimir
    Sarantou, Terry
    White, Richard L.
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345